Home ›Top Stories ›DCGI approves commercial launch of low cost COVID-19 test 'Feluda'
MASIGNASUKAv102
6510051498749449419

DCGI approves commercial launch of low cost COVID-19 test 'Feluda'

DCGI approves commercial launch of low cost COVID-19 test 'Feluda'
The Drugs Controller General of India has approved the commercial launch of 'Feluda', the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on Saturday.

from IndiaTV: Google News Feed https://ift.tt/2EkOtJW
Ankkit

Related Post

comment 0 Comments

more_vert

:)
:(
hihi
:-)
:D
=D
:-d
;(
;-(
@-)
:P
:o
-_-
(o)
[-(
:-?
(p)
:-s
(m)
8-)
:-t
:-b
b-(
:-#
=p~
$-)
(y)
(f)
x-)
(k)
(h)
(c)
cheer
(li)
(pl)
Emoticon Feedback